CLINICAL_TRIALS
trial_result
· 2014-02-11
Clinical Trial Update: Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of OXC XR as adjunctive therapy for partial seizures; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2014-02-11